10.25384/SAGE.21753987
Katrin Pape
Katrin
Pape
Leoni Rolfes
Leoni
Rolfes
Düsseldorf University Hospital
University Hospital Münster
Heinrich Heine University Düsseldorf
Falk Steffen
Falk
Steffen
University Medical Center of the Johannes Gutenberg University Mainz
Muthuraman Muthuraman
Muthuraman
Muthuraman
University Medical Center of the Johannes Gutenberg University Mainz
Melanie Korsen
Melanie
Korsen
Sven G. Meuth
Sven G.
Meuth
Düsseldorf University Hospital
University Hospital Münster
Heinrich Heine University Düsseldorf
Frauke Zipp
Frauke
Zipp
Johannes Gutenberg University of Mainz
Stefan Bittner
Stefan
Bittner
University Medical Center of the Johannes Gutenberg University Mainz
Johannes Gutenberg University of Mainz
sj-docx-1-tan-10.1177_17562864221142924 – Supplemental material for Comparative effectiveness of natalizumab versus ocrelizumab in multiple sclerosis: a real-world propensity score–matched study
<p>Supplemental material, sj-docx-1-tan-10.1177_17562864221142924 for Comparative effectiveness of natalizumab versus ocrelizumab in multiple sclerosis: a real-world propensity score–matched study by Katrin Pape, Leoni Rolfes, Falk Steffen, Muthuraman Muthuraman, Melanie Korsen, Sven G. Meuth, Frauke Zipp and Stefan Bittner in Therapeutic Advances in Neurological Disorders</p>
110904 Neurology and Neuromuscular Diseases
111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
SAGE Journals
2022
2022-12-20
2022-12-20
Journal contribution
705641 Bytes
10.1177/17562864221142924
CC BY-NC 4.0